Loss of independence in early Parkinson disease: A 5-year population-based incident cohort study

Neurology

Volumn 87, Issue 15, 2016, Pages 1599-1606

  Bjornestad, Anders ^a   Tysnes, Ole Bjorn ^b,c   Larsen, Jan Petter ^a   Alves, Guido ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT;

AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; FALLING; FEMALE; HALLUCINATION; HEALTH CARE FACILITY; HEALTH STATUS; HUMAN; INDEPENDENCE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SYMPTOM; UNIFIED PARKINSON DISEASE RATING SCALE; CLINICAL TRIAL; COGNITIVE DYSFUNCTION; COMORBIDITY; COMPLICATION; FOLLOW UP; HALLUCINATIONS; INCIDENCE; INDEPENDENT LIVING; LONG TERM CARE; LONGITUDINAL STUDY; MULTICENTER STUDY; PREVALENCE; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS;

ACCIDENTAL FALLS; AGED; COGNITIVE DYSFUNCTION; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HALLUCINATIONS; HUMANS; INCIDENCE; INDEPENDENT LIVING; LONG-TERM CARE; LONGITUDINAL STUDIES; MALE; PARKINSON DISEASE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84992052346     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003213     Document Type: Article

References (34)

1. Bowling A, Gabriel Z, Dykes J, et al. Let's ask them: a national survey of definitions of quality of life and its enhancement among people aged 65 and over. Int J Aging Hum Dev 2003;56:269-306.
2. McGhee D, Parker A, Fielding S, Zajicek J, Counsell C. Using "dead or dependent" as an outcome measure in clinical trials in Parkinson's disease. J Neurol Neurosurg Psychiatry 2015;86:180-185.
3. Macleod AD, Grieve JW, Counsell CE. A systematic review of loss of independence in Parkinson's disease. J Neurol 2015;86:2006-2009.
4. Poewe W. The natural history of Parkinson's disease. J Neurol 2006;253(suppl 7):VII2-VII6.
5. Chen JJ, Fernandez HH. Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors. Drugs Aging 2007; 24:663-680.
6. Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 2000;48:938-942.
7. Mitchell SL, Kiely DK, Kiel DP, Lipsitz LA. The epidemiology, clinical characteristics, and natural history of older nursing home residents with a diagnosis of Parkinson's disease. J Am Geriatr Soc 1996;44: 394-399.
8. Buchanan RJ, Wang S, Huang C, Simpson P, Manyam BV. Analyses of nursing home residents with Parkinson's disease using the minimum data set. Parkinsonism Relat Disord 2002;8:369-380.
9. Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993;43:2227-2229.
10. Bjornestad A, Tysnes OB, Larsen JP, Alves G. Reliability of three disability scales for detection of independence loss in Parkinson's disease. Parkinsons Dis 2016;2016: 1941034.
11. Alves G, Muller B, Herlofson K, et al. Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 2009;80: 851-857.
12. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-2653.
13. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
14. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42:1142-1146.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
16. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 2003;56: 221-229.
17. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
18. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134: 382-389.
19. Fahn S, Elton R. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Healthcare Information; 1987: 153-163.
20. Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004;19: 1020-1028.
21. Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force Guidelines. Mov Disord 2012;27:349-356.
22. Pedersen KF, Larsen JP, Tysnes OB, Alves G. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol 2013;70:580-586.
23. Kempster PA, O'Sullivan SS, Holton JL, Revesz T, Lees AJ. Relationships between age and late progression of Parkinson's disease: a clinico-pathological study. Brain 2010;133:1755-1762.
24. Forsaa EB, Larsen JP, Wentzel-Larsen T, et al. A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol 2010;67:996-1001.
25. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-1707; quiz 1837.
26. Alves G, Lange J, Blennow K, et al. CSF Abeta42 predicts early-onset dementia in Parkinson disease. Neurology 2014;82:1784-1790.
27. O'Reilly F, Finnan F, Allwright S, SmithGD, Ben-Shlomo Y. The effects of caring for a spouse with Parkinson's disease on social, psychological and physical well-being. Br J Gen Pract 1996;46:507-512.
28. Vossius C, Nilsen OB, Larsen JP. Parkinson's disease and nursing home placement: the economic impact of the need for care. Eur J Neurol 2009;16:194-200.
29. Hiorth YH, Lode K, Larsen JP. Frequencies of falls and associated features at different stages of Parkinson's disease. Eur J Neurol 2013;20:160-166.
30. Factor SA, Steenland NK, Higgins DS, et al. Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis. J Neurol Neurosurg Psychiatry 2011;82:564-568.
31. Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord 2006; 21:1123-1130.
32. Abendroth M, Lutz BJ, Young ME. Family caregivers' decision process to institutionalize persons with Parkinson's disease: a grounded theory study. Int J Nurs Stud 2012;49:445-454.
33. McLennon SM, Habermann B, Davis LL. Deciding to institutionalize: why do family members cease caregiving at home? J Neurosci Nurs 2010;42:95-103.
34. Tanner CM. A second honeymoon for Parkinson's disease? N Engl J Med 2013;368:675-676.